Pfizer today announced the successful completion of its offering of $13.5 billion of senior unsecured notes. The notes consist of: — $1.25 billion of floating rate notes due 2011 — $3.50 billion of 4.45% notes due 2012 — $3.00 billion of 5.35% notes due 2015 — $3.25 billion of 6.20% notes due 2019 — $2.50 billion of 7.20% notes due 2039. Pfizer intends to use the net offering proceeds for general corporate purposes, including funding a portion of the purchase price of the proposed Wyeth acquisition and the refinancing of existing debt. Pfizer may also temporarily invest funds that are not immediately needed for these purposes in short-term marketable securities.
